Sonoma Pharmaceuticals, Inc.
SNOA
$1.11
-$0.03-2.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 29.06% | -53.37% | 56.97% | -59.92% | 16.38% |
| Total Depreciation and Amortization | -2.94% | -5.56% | 0.00% | 16.13% | -6.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -230.77% | -154.55% | 147.99% | -194.30% | 1,028.57% |
| Change in Net Operating Assets | 189.90% | 135.36% | 45.31% | -253.29% | -76.68% |
| Cash from Operations | 32.07% | -20.31% | 68.49% | -2,021.05% | -116.81% |
| Capital Expenditure | 38.30% | -370.00% | 90.57% | -125.53% | -2,250.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 38.30% | -370.00% | 90.57% | -125.53% | -2,250.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 8.93% | 32.53% | -2.47% | 0.00% | 1.22% |
| Issuance of Common Stock | -39.47% | 1,166.67% | -8.70% | -53.06% | -93.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 84.29% | 438.71% | -6.90% | -123.97% | -65.82% |
| Foreign Exchange rate Adjustments | -100.79% | -7.30% | -66.59% | 978.95% | 133.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.82% | 16.84% | 67.78% | -1,381.88% | -88.08% |